Group 1: Overall Business Performance - In 2024, the company achieved a revenue of 5.67 billion CNY, a year-on-year increase of 45.33% [2] - Net profit attributable to shareholders was 336 million CNY, a decline of 46.99% compared to the previous year [2] - The decrease in net profit was primarily due to a significant drop in non-recurring gains from the sale of overseas warehouses [2][3] Group 2: Overseas Warehouse Operations - The number of self-operated overseas warehouses increased from 12 to 21, with total operational area expanding by 128.63% to 662,100 square meters by the end of 2024 [4] - The company served 1,175 outbound enterprises, with over 11 million packages shipped [4] - Current warehouse utilization is between 60%-70%, with new warehouses at 40%-50% utilization expected to rise [5] Group 3: New Product Development and Profitability - New products, including ergonomic chairs and electric sofas, accounted for over 10% of cross-border e-commerce revenue in 2024 [6] - The company aims to increase the sales proportion of new products to 15%-20% in the future [6] - New products have similar gross margins to traditional products, but higher marketing costs reduce net profit [6] Group 4: Impact of Trade Tariffs - Some customers are hesitant to ship due to concerns over tariffs, while larger sellers continue to ship to maintain platform rankings [7] - The company has raised prices and is utilizing factories in Vietnam to mitigate the impact of a 10% tariff [7] Group 5: Future Outlook - The company aims to maintain steady growth in 2025, focusing on smart home and overseas warehouse sectors [7] - Plans include enhancing product offerings in smart home and health office categories, and strengthening brand development [7]

证券简称：立中集团 证券代码：300428 投资者关系活 动类别 □特定对象调研 □分析师会议 □媒体采访 ■业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 参与单位名称 及人员姓名 63 家机构，具体内容详见附件。 时间 2025 年 4 月 21 日 上市公司接待 人员姓名 立中集团副总裁、董事会秘书李志国；立中集团证券事务代表冯 禹淇。 投资者关系活 动主要内容介 绍 1、公司 2024 年业绩和各业务板块的经营情况如何？ 答：2024 年，公司积极应对国内外市场及行业竞争压力，充 分发挥产业链协同优势，聚焦主营业务，提升运营效能，深入开 拓市场与客户资源，全力推动高附加值产品的研发与市场开拓， 落实降本增效策略，持续提升公司盈利能力。2024 年累计实现营 业收入 2,724,637 万元，较上年同期增长 16.61%，累计实现归属 于上市公司股东的净利润为 70,712 万元，较上年同期增长 16.77%，剔除股权激励费用归属于上市公司股东的净利润为 74,723 万元，较上年同期增长 5.31%。 （1）功能中间合金业务 功能中间合金业务始终保持行业龙头优势，公司积极布局高 端新兴产业， ...

Financial Performance - In 2024, the company achieved a revenue of CNY 13.466 billion and a net profit of CNY 2.583 billion attributable to shareholders [2] - JinSai Pharmaceutical contributed CNY 10.671 billion in revenue and CNY 2.678 billion in net profit [2] - R&D investment reached CNY 2.690 billion, an increase of 11.20% year-on-year, accounting for 19.97% of revenue [2] - Sales expenses increased to CNY 4.439 billion, a year-on-year growth of 11.81% [2] Q1 2025 Performance - In Q1 2025, the company reported a revenue of CNY 2.997 billion and a net profit of CNY 0.473 billion [3] - JinSai Pharmaceutical generated CNY 2.617 billion in revenue and CNY 0.535 billion in net profit [3] Product Sales and Market Strategy - Long-acting growth hormone revenue constituted approximately 32% of growth hormone product sales in 2024, increasing to 35% in Q1 2025 [5] - Nutritional products saw a revenue increase of nearly 60% in 2024 [5] - The company is focusing on enhancing market promotion and compliance in its sales strategy [10] R&D and Innovation - The company has 9 innovative drugs in clinical stages, including treatments for various conditions such as rheumatoid arthritis and ovarian cancer [6] - The international sales of JinSai Pharmaceutical saw a remarkable growth of 454% year-on-year, with emerging markets like Algeria becoming significant growth points [3] Management and Operational Adjustments - Management expenses rose to CNY 1.202 billion, a 25.59% increase due to structural adjustments in JinSai Pharmaceutical [3] - The company terminated its stock incentive plan, resulting in a one-time expense of CNY 0.055 billion [3] - A total of CNY 1.33 billion in capitalized development expenses was written off due to project termination [3] Future Outlook - The company aims to enhance its internationalization strategy and increase participation in major academic conferences to boost market recognition of its innovative products [9] - Plans to optimize the real estate business and explore new operational models are underway to improve financial efficiency [12]

软件系统以及生态运营一体化的解决方案。硬件方面，公司深度参与了数字人民 币的运营及兑换环节，参与六大行多个数字人民币钱包推广项目，在文旅消费、 地铁出行、零售购物、边境贸易等多个数币场景实现突破。目前公司正全力抢占 外币自助兑换解决方案市场，公司推出的数字人民币外币兑换机支持港币、美元、 英镑、日元、欧元等实时兑换，可在出入境关口、机场、涉外酒店、国际展览中 心、对外贸易区以及银行网点等场景为境内外人士提供 7*24 小时外币自助兑换服 务，极大提升支付便利性。公司外币自助兑换解决方案已经在工商银行、农业银 行、建设银行、交通银行、广发银行等国有大行及股份制银行落地。近日，由公 司主导的面向多元场景的 AR 数字人民币硬钱包关键技术与应用示范项目获颁十 五运会和残特奥会广州赛区科技创新应用立项证书。数币 AR 硬钱包即将亮相"十 五运"，首次实现赛事侧与城市侧多场景覆盖，直击跨境支付痛点，为粤港澳大 湾区三地资金流动、商贸往来提供标准化解决方案。软件方面，公司为诸多商业 银行及机构提供智能合约、数字人民币支付通道、核心业务系统等生态产品。2024 年，公司在数字人民币跨境贸易场景的应用上取得重要突破，中标了千 ...

珠海光库科技股份有限公司 投资者关系活动记录表 编号：2025001 | 投资者关 | □特定对象调研 | □分析师会议 | □媒体采访 | 业绩说明会 | | --- | --- | --- | --- | --- | | 系活动类 | □新闻发布会 | □路演活动 | □现场参观 | | | 别 | □其他 | | | | | 参与单位 | | | | | | 及人员姓 | 线上参与公司2024年年度报告网上说明会的投资者 | | | | | 名 | | | | | | 时间 | 2025年4月18日下午15:00-16:00 | | | | | 地点 | 同花顺路演平台 | | | | | 上市公司 | 联席董事长、总经理Wang Xinglong先生；副总经理吉贵军先生；独立董事刘 | | | | | 接待人员 | 成昆先生；副总经理、董事会秘书吴炜先生；财务总监姚韵莉女士；保荐代表 | | | | | 姓名 | 人胡彦威先生。 | | | | | | 公司与本次参与业绩说明会的投资者进行了网上互动交流，就投资者关注的 | | | | | | 问题进行了回复。具体问题回复如下： | | | | | ...

Group 1: Financial Performance - In 2024, the company achieved an operating revenue of 10.263 billion yuan, a year-on-year increase of 2.71%, and a net profit attributable to shareholders of 1.88 billion yuan, up 17.89% [3] - In Q1 2025, the company reported an operating revenue of 3.405 billion yuan, a year-on-year increase of 29.56%, with a net profit of 288 million yuan, up 20.84% [3] Group 2: Sales and Production Insights - In 2024, the compound fertilizer sales reached 3.3464 million tons, a year-on-year increase of 12.68%, while the production of monoammonium phosphate surged by 93.8% [3] - The retail sales of horticultural fertilizers reached 4.411 billion yuan, marking a 40.86% increase, with a total of 6.09 million units sold, up 87.96% [3] Group 3: Market Dynamics - The growth of leading companies in the compound fertilizer industry is driven by increased industry concentration, as smaller firms exit the market due to supply-side reforms and stricter environmental regulations [3] - The company anticipates stable growth in the compound fertilizer market despite the zero growth policy for chemical fertilizers, as the planting area for economic crops increases [8] Group 4: Raw Material Price Trends - The company predicts that potassium fertilizer prices may decrease due to negotiations with suppliers, while urea prices are influenced by export policies, which may lead to further price adjustments [4][5] - The future price trends for sulfur and phosphate rock remain uncertain, dependent on export policies and market dynamics [10] Group 5: Subsidiary Performance - The subsidiary Lihe Fertilizer is expected to achieve a profit of approximately 93 million yuan in 2024, while the subsidiary Songzi New Materials is projected to incur a loss of 112 million yuan due to initial production costs [6] - The profitability of Songzi New Materials is expected to improve in the latter half of 2025 as production stabilizes [6] Group 6: Capital Expenditure and Dividends - The company's capital expenditure for 2025 is primarily allocated to settling project payments for Songzi New Materials and relocating the Guangxi Guigang compound fertilizer project, estimated at no more than 400 million yuan [7] - The company plans to enhance cash dividend levels, supported by a strong cash position [7] Group 7: Brand and Sales Strategy - The company is shifting marketing expenses from online to offline channels, focusing on direct sales to large customers and enhancing brand value [10] - The company is leveraging CRM systems for better customer management and expanding its sales force to support direct sales to large agricultural operators [10]

Group 1: Impact of Tariffs - The company's domestic sales accounted for 51.99% of total revenue, while export sales made up 48.01%, indicating a higher reliance on domestic markets [1] - The company has shifted its export capacity to Vietnam to mitigate the impact of U.S. tariffs, resulting in minimal effects on its overall operations [1] - The tariff situation may accelerate industry consolidation, as smaller manufacturers lacking international capabilities may lose orders, prompting clients to seek more stable suppliers [2] Group 2: Aviation Engine Sector - The company entered the aviation engine sector in 2014 and has developed five major aviation power platforms, launching over 20 derivative products [2] - The company aims to become a leading domestic and internationally recognized player in the small to medium-sized aviation power market [2] Group 3: Technological Transformation - The company believes that there are no sunset industries, only sunset enterprises, and has solidified its leadership position through digitalization and smart manufacturing [3] - Efforts to enhance production management efficiency and core competitiveness are ongoing, with significant growth potential anticipated [3] Group 4: Stock Performance and Market Perception - The company's strong fundamentals and continuous profitability have not yet been reflected in its stock price, which is influenced by broader market sentiment and expectations [3] - The company projects a 70%-100% increase in net profit attributable to shareholders for Q1 2025, showcasing its operational efforts and industry context [3]

证券代码：000739 证券简称：普洛药业 普洛药业股份有限公司 投资者关系活动记录表 编号：2025-03 | 投资者关系活动 | ■其他 （投资者电话交流会） | | --- | --- | | 类别 | | | | 山西证券（邓周宇、刘浩然、魏赟、张智勇）；国盛证券（胡偌碧、 | | | 徐雨涵）；太平洋医药（周豫、乔露阳）；广发证券（罗佳荣、田鑫、 | | | 方程嫣）；中信证券（陈竹、王凯旋、韩世通、王郑洋）；中信建投 | | | 证券（贺菊颖、王云鹏、赖俊勇、袁清慧、刘若飞）；招商证券（侯 | | | 彪、许菲菲）；浙商医药（郭双喜、盖文化）；东吴医药（俞昊岚）； | | | 华源证券（陶宸冉）；兴业证券（乔波耀）；天风证券（刘一伯）； | | | 西部证券（邓琳茜）；信达证券（贺鑫）；华西证券（孙曼）；华泰 | | | 证券（李奕玮）；华福证券（王宣宇）；国信证券（彭思、高熹）； | | | 国泰海通（周航、吴晗）；申万医药（余玉君）；财通证券（邹一瑜）； | | | 中泰证券（祝嘉琦）；开源证券（阮帅）；平安证券（李峰）；中金 | | | 公司（吴婉桦）；中海基金（陈玮）；浙商证券（赵媛）；易 ...

Group 1: Strategic Business Layout - The company achieved over threefold growth in shipments and revenue in the smart robot segment in 2024 compared to 2023, with Q1 2025 continuing to exceed expectations [2][3] - The strategic goal is to become a leading SoC chip supplier in the smart robot industry by enhancing market share and entering high-end markets [3] - New products launched in the past two years have received positive market feedback, with strong growth observed in 2024 and Q1 2025 [3][4] Group 2: Financial Performance - In 2024, the company reported revenue of approximately 2.354 billion yuan, a year-on-year increase of about 16.49%, and a net profit of approximately 256 million yuan, up 25.18% [8] - For Q1 2025, revenue reached approximately 665 million yuan, reflecting a year-on-year growth of about 26.36% [9] - The smart security business line contributed approximately 1.588 billion yuan, accounting for about 68.81% of total revenue in 2024 [8] Group 3: Research and Development - The company increased R&D investment to approximately 602 million yuan in 2024, a year-on-year increase of about 21.95%, with an R&D investment rate of approximately 25.59% [11] - In Q1 2025, R&D investment was about 168 million yuan, up 19.8% year-on-year, maintaining a high investment rate [11] - The focus on R&D aims to break through industry homogenization and build a sustainable competitive advantage [11] Group 4: Market Strategy - The company adopted a proactive pricing strategy to enhance product sales and market share, aiming to build customer loyalty and trust [12] - The long-term outlook suggests a more stable market structure, with expectations for increased market share and improved profitability [12] Group 5: Impact of U.S. Tariff Policies - The impact of U.S. tariffs on the company is limited, as products are not directly exported to the U.S. and the indirect export ratio is low [13][14] - The company’s end customers have global supply chain layouts, which can mitigate tariff impacts through capacity adjustments and cost sharing [14] - Continuous market expansion and R&D investment are planned to enhance product value and strengthen risk resilience [14]

Group 1: Project Delivery and Development - The Tianjin Baodi project is expected to complete its first and second phases by mid-2025, with revenue generation starting thereafter [1][2] - The company has acquired 368 acres of industrial land in Tianjin Baodi for the third phase, which has received energy consumption indicators and will be developed based on market demand [2][3] - The overall planning for the Tianjin Phase III project is 140 MW, while the Inner Mongolia and Hohhot projects are planned for 63 MW and 100 MW respectively [4][5] Group 2: Market Conditions and Pricing - The current market supply-demand relationship shows no significant changes, with considerable price pressure [3][4] - Demand primarily comes from leading internet companies and cloud service providers, with competitive pressure leading to lower prices [4] - The rental price for computing power has decreased by 30-40% compared to the same period last year [5] Group 3: Energy Efficiency and Sustainability - The company is focusing on green energy requirements for data centers, utilizing solar systems in various locations to meet these demands [5] - The average energy utilization efficiency and renewable energy utilization rates are being improved in response to national policies promoting low-carbon development [2][3] Group 4: Financial Performance and Challenges - The company's cloud computing business is expected to be impacted by the disposal of assets related to Amazon, with an estimated profit reduction of approximately 100 million due to this [4] - The subsidiary Kexin Shencai reported losses due to client strategy adjustments leading to decreased revenue [4]